ASPIRIN
- Product NDC
- 50332-0139
- 11-digit product format
- 503320139
- Labeler code
- 50332
- Product ID
- 50332-0139_356da65e-7683-4116-aaef-a4c8decd1297
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- ASPIRIN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- HART Health
- Application
- M
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2023-01-01
- Substance
- ASPIRIN
- Active strength
- 325 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ASPIRIN
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ASPIRIN | 325 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| R16CO5Y76E | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 212033 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| a1c73edf-861d-478b-9d3c-0eddcc6879cc | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d7724692-1155-4cc8-a415-22f5fc4aec35 | Product name | 6 | 20220216 |
| bde672ba-4805-28d0-1986-73543d41b412 | Product name | 2 | 20210201 |
| f212291f-05fe-9603-fc7e-bd73e38ce1e6 | Product name | 2 | 20161129 |
| ade821ba-260a-47e2-bd89-743e27ac9906 | Product name | 1 | 20161121 |
| 182f9ab4-4ab5-c449-200f-87ce2ce8e550 | Product name | 2 | 20151105 |
| 9425d234-4ae1-4b53-adc6-8cc7af6dd657 | Product name | 1 | 20150929 |
| 2a21311a-89e2-0e83-2ebd-117f9798b2b2 | Product name | 1 | 20140508 |
| 9007e8a7-ff50-f9b9-7945-f2a1deadd94e | Product name | 1 | 20140508 |
| 96c2be53-8e44-452d-56a2-d255b2f1af2d | Product name | 1 | 20140508 |
| bf8bd5f7-495f-4022-2780-7ded7ea7ea44 | Product name | 1 | 20140508 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50332-0139 | ASPIRIN TABLET [HART HEALTH] | 1 | Current NDC | 20240125_a1c73edf-861d-478b-9d3c-0eddcc6879cc.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CLARUS Antifungal | TOLNAFTATE | Clinical Therapeutic Solutions | 835c3c23-fc3c-404e-8e87-5a0176126730 | 2024-02-28 | Warnings | M |
| MAX relief junior | ACETAMINOPHEN | ATLANTIC BIOLOGICALS CORP. | 396903dc-ae2d-4bf4-b1fd-0017b84abef9 | 2024-02-28 | Warnings | M |
| MAX relief junior | ACETAMINOPHEN | ATLANTIC BIOLOGICALS CORP. | 44730cbd-5b98-49bd-b3b8-6fecb0ccd153 | 2024-02-28 | Warnings | M |
| HYDROCORTISONE | HYDROCORTISONE ACETATE | HART Health | 779f945f-ab69-40de-8d86-ab76debc5c7c | 2024-02-16 | Warnings | M |
| First Aid and Burn | BENZALKONIUM CHLORIDE, LIDOCAINE | HART Health | f5746bba-9d7f-4691-b466-14985473bf14 | 2024-02-16 | Warnings | M |
| IBUPROFEN | IBUPROFEN | HART Health | 1c1374e1-890f-48ab-8f93-e84da9d5bf84 | 2024-01-25 | Warnings | M |
| Hand Sanitizer | ANTISEPTIC GEL | HART Health | f07daf29-d0db-4cf8-8baf-d175c2b2ef50 | 2024-01-25 | Warnings | M |
| Hydrogen Peroxide | HYDROGEN PEROXIDE | HART Health | 0346a322-8f6e-405a-8d17-8bc6ce5105a3 | 2024-01-24 | Warnings | M |
| Alcohol | ISOPROPYL ALCOHOL | NorMed | 441b915a-287f-4734-b4d9-730b3d95e04c | 2024-01-24 | Warnings | M |
| Sooth-a-Sting | BENZOCAINE | HART Health | bd7229b6-813a-4149-bfe2-fe682f270ff4 | 2024-01-18 | Warnings | M |
| First Aid | BENZALKONIUM CHLORIDE, BENZOCAINE | HART Health | a6d258ed-6d6d-42f0-9994-6c2c4c3d0f4a | 2024-01-18 | Warnings | M |
| TRIBIOTIC | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | HART Health | d8f175f9-f526-4c73-a171-49309ca16cb0 | 2024-01-18 | Warnings, Adverse reactions | M |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 212033 | aspirin 325 MG Oral Tablet | PSN | a1c73edf-861d-478b-9d3c-0eddcc6879cc | 2 |
| 212033 | aspirin 325 MG Oral Tablet | SCD | a1c73edf-861d-478b-9d3c-0eddcc6879cc | 2 |
| 212033 | ASA 325 MG Oral Tablet | SY | a1c73edf-861d-478b-9d3c-0eddcc6879cc | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 50332-0139-3 | 50332013903 | 25 PACKET in 1 BOX, UNIT-DOSE (50332-0139-3) / 2 TABLET in 1 PACKET | 25 packet | 2023-01-01 | No | No | Current |
| 50332-0139-4 | 50332013904 | 50 PACKET in 1 BOX, UNIT-DOSE (50332-0139-4) / 2 TABLET in 1 PACKET | 50 packet | 2023-01-01 | No | No | Current |
| 50332-0139-7 | 50332013907 | 125 PACKET in 1 BOX, UNIT-DOSE (50332-0139-7) / 2 TABLET in 1 PACKET | 125 packet | 2023-01-01 | No | No | Current |
| 50332-0139-8 | 50332013908 | 250 PACKET in 1 BOX, UNIT-DOSE (50332-0139-8) / 2 TABLET in 1 PACKET | 250 packet | 2023-01-01 | No | No | Current |